PPIDT00081
Drug Information
| Name | Becaplermin |
|---|---|
| Sequence | SLGSLTIAEPAMIAECKTRTEVFEISRRLIDRTNANFLVWPPCVEVQRCSGCCNNRNVQCRPTQVQLRPVQVRKIEIVRKKPIFKKATVTLEDHLACKCETVAAARPVT |
| DrugBank_ID | DB00102 |
| Type | biotech |
| Indication | For topical treatment of skin ulcers (from diabetes) |
Dosage Forms
| Form | Route | Strength |
|---|---|---|
| Gel | Cutaneous |
0.0001
|
| Gel | Topical |
100 ug/1g
|
| Gel | Topical |
100 mcg / g
|
| Gel | Topical |
0.01 g
|
Target Information
| Role | Uniprot_ID | Gene_Name | Entity_Name | Organism | Actions | Internal link |
|---|---|---|---|---|---|---|
| target | P09619 | PDGFRB | Platelet-derived growth factor receptor beta | Homo sapiens | inhibitor | Link |
| target | P16234 | PDGFRA | Platelet-derived growth factor receptor alpha | Homo sapiens | unknown | Link |
| target | P01023 | A2M | Alpha-2-macroglobulin | Homo sapiens | unknown | Link |